Capecitabine 82511-0001
Product NDC
82511-0001- Manufacturer
- Teyro Labs Private Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 16, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA217237
Need to source Capecitabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Capecitabine | 150 mg/1 |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(1)
60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82511-001-15)